China Resources Double-Crane Pharmaceutical Co Ltd

SSE:600062

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is China Resources Double-Crane Pharmaceutical Co Ltd's stock price target?

Price Target

26.09 CNY

According to Wall Street analysts, the average 1-year price target for China Resources Double-Crane Pharmaceutical Co Ltd is 26.09 CNY with a low forecast of 25.25 CNY and a high forecast of 27.3 CNY.

What is China Resources Double-Crane Pharmaceutical Co Ltd's Revenue forecast?

Projected CAGR

8%

For the last 8 years the compound annual growth rate for China Resources Double-Crane Pharmaceutical Co Ltd's revenue is 9%. The projected CAGR for the next 3 years is 8%.

What is China Resources Double-Crane Pharmaceutical Co Ltd's Operating Income forecast?

Projected CAGR

15%

For the last 8 years the compound annual growth rate for China Resources Double-Crane Pharmaceutical Co Ltd's operating income is 10%. The projected CAGR for the next 3 years is 15%.

What is China Resources Double-Crane Pharmaceutical Co Ltd's Net Income forecast?

Projected CAGR

11%

For the last 8 years the compound annual growth rate for China Resources Double-Crane Pharmaceutical Co Ltd's net income is 9%. The projected CAGR for the next 3 years is 11%.